(20) found that the overexpression of NR2F6 can promote the phenotype of ovarian cancer stem cells, while the knockdown of NR2F6 can inhibit it and make ovarian cancer cells sensitive to chemotherapeutics. This evidence concerns the gene NR2F6 and ovarian cancer.